
Gene knockout cell lines are generated using CRISPR-Cas9 based technology to precisely disrupt target genes, enabling functional genomics research, disease modeling, and target validation.
ZNF496 (zinc finger protein 496) encodes a zinc finger DNA-binding transcription factor predicted to recognize RNA polymerase II cis-regulatory regions. It is involved in the positive regulation of DNA-templated transcription and broader regulation of RNA polymerase II-dependent gene expression. The protein is predicted to function in the nucleus, where its sequence-specific DNA-binding activity may contribute to transcriptional control and regulation of cellular gene expression.
5637 is a human bladder carcinoma cell line established from a primary bladder tumor of a 68-year-old male patient. The cells are known to produce multiple growth factors, including stem cell factor (SCF), interleukins, and colony-stimulating factors. 5637 cells are used as a model for studying bladder cancer biology, tumor-associated signaling, and growth factor regulation.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?